[1]. Lin F, Lan C. Antimicrobial resistance in Acinetobacter baumanni: From bench tobedside. Word J Clin Cases. 2014; 2(12):787-814.
[2]. Manchanda V, Sanchaita S, Singh. Multidrug resistant Acinetobacter. JGlob Infect Dis. 2010;2(3):291-304.
[3]. Isler B, Doi y, Bonomo R, Paterson D. New Treatment Options Against Carbapenem-Resistant Acinetobacter baumanni Infections. Antimicrobial Agentsand Chemotherapy.2018:1-19.
[4]. Tatti C, Leski T, Stockelman M, Craft D, Zurawski D, Krikup B. Antimicrobial Resistance Determinants in Acinetobacter baumanni Isolates Taken from Military Treatment Facilities.Antimicrobial Agents and Chemotherapy.2014;58(2):767-781.
[5]. Shanks R, Kadouri D. Predatory prokaryotes wage war against eye infections. Future Microbiol.2014;9(4):429-432.
[6]. Dwidar M, Monnappa A, Mitchell R. The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB reports. 2012;45(2):71-78.
[7]. Sinha A, Hurakadli M, Ravindra S, Agarwal A. Bdellovibrio and Like Organisms: The Predatory Assassin. IOSR Journal of Dental and Medical Sciences.2014;13(10): 32-36.
[8]. Sar T, Umeh E, Akosu D. Occurrence, Detection and Isolation of Bdellovibrio spps. From some Fresh Water Bodies in Benue State, Nigeria. Microbiology Journal.2015;5(1):21-27.
[9]. Taylor R. Delt Proteobacter. Current Protocols in Microbiology. 2005: 1-7.
[10]. Lambert C, Sockett R. Laboratory Maintenance of Bdellovibrio. Current Protocols in Microbiology.2008: 1-13.
[11]. Oyedara O, Luna-Santilla E, Olguin-Rodriguez O, Guo X. Isolation ofBdellovibrio sp. from soil samples in Mexico and their potential applications in control of pathogens. Microbiology Open.2016: 1-11doi:10.1002/mbo3.382.
[12]. Feng S, Tan C, Cohen Y, Rice S.Isolation of Bdellovibrio bacteriovorus from tropical wastewater treatment plant and predation of mixed species biofilms assembled by the native community members. Wiley-Blackwell and Society for Applied Microbiology.’Accepted Article’,doi:10.1111/1462-2920.13384.
[13]. Lu F, Cai J. The protective effect of ., Bdellovibrio and like organisms on tilapia fish fillets against salmonella entrica spp. Entrica serovar Typhimurium.Applied Microbiology. 2010;51:625-631.
[14]. Dashiff A, Junka R, Libera M, Kadouri D. Predation of human pathogens by the predatory bacteria Micavibrio
aeroginosavorus and Bdellovibrio bacteriovorus. Journal of applied Microbiology.2010; 110:431-444.
[15]. Russo R, Chae R, Mukherjee S, Singleton E, Occi J, Kadouri D, Connell N. Susceptibility of Select A gents to Predation by Predatory Bacteria. Microorganisms.2015; 3: 903-912.
[16]. Wan-Yebob s. Identification and Characterization of Bdellovibrio bacteriovorus, a Predator of Burkholderia glumae. Journal of Microbiology and Biotechnology.2004; 14(1): 4855.
[17]. El-shanshoury A, Abo-Amer A. Isolation of Bdellovibriosp. from wastewater and their potential application in control of Salmonella paratyphi in water. Geomicrobiology. 2016; 33(10): 886-893.
[18]. Markelova N. The potential of Bdellovibrio For the Biocotrol of the Infectious Agents Vibrio cholera. Avicenna J Environ Health Eng. 2015; 2(2): 41-45.
[19]. Kongrueng J, Mitraparp P, Bangpanwimon K, Robins W, Vuddhakul V, Mekalanos J. Isolation of Bdellovibrio and Like Organisms and potential to reduce acute hepatopancreatic necrosis disease caused by Vibrio parahaemolyticus. Dis Aquat Org. 2017; 124: 223-232.
[20]. Chu W, Zhu W. Isolation of Bdellovibrio as Biological Therapeutic Agents used For the Treatment of Aeromonas hydrophila Infection. Zoonoses and Public Heaith. 2009:1-7 Doi:10.111/j.1863-2378.2008.01224.x.
[21]. Atterbury R, Hobley L, Till R, Capeness M, Lerner T, Fenton A, Barrow P, Sockett E. Effect of Orally Administered Bdellovibrio bacteriovorus on the Well-Being and Salmonella Colonization of Yong Chicks. Applied and Environmental Microbiology. 2001: 5794-5803.
[22]. Boileau M, Clinkenbeard K, Iandolo J. Assessment of Bdellovibrio bacteriovorus109J killing of Moraxella bovis in an in vitro model of infectious bovine Keratoconjuctivitis.The Canadian Journal of Veterinary Research .2011; 75:285-291.
[23]. Maragakis L, Perl T. Acinetobacter baumanni Epidemiology, Antimicrobial Resistance, and Treatment Options. Antimicrobial Resistance. 2008;46:1254-1263.
[24]. Sockett E, Lambert C. Bdellovibrio as therapeutic agents: a predatory renaissance. Nature.2004;2: 669-675.
[25]. Strauch E, Beck S, Appel B. Bdellovibrio and Like Organisms: Potential Sources for New Biochemicals and Therapeutic Agents?. Microbiol Monogr.2006:132-148.
[26]. Shanks R, Davar V, Romanowski E, Brothers K, Stella N, Godboley D, Kadouri D. An Eye to a Kill:Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections.PLOS.2013; 8(6):1-7.